Current Controlled Trials - Search the ISRCTN Register of Clinical Trials.

Welcome

10 February 2012

	Trial registration
	Unique identification scheme
	International databases

Find trials

ISRCTN Register

Registration

New application

Updating record

Information

introduction

governing board

ISRCTN FAQs

data set

guidance notes

International Standard Randomised Controlled Trial Number Register

Showing records: 6081 to 6090 of 10349

SEARCH FOR	RESULTS ORDER	DIRECTION	MAX RESULTS

6081	Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass
	ISRCTN:	ISRCTN48331653
	Sponsor:	University of Dundee (UK)
	Date assigned:	29 March 2006

6082	Does aldosterone blockade improve endothelial dysfunction in patients with coronary artery disease but without heart failure?
	ISRCTN:	ISRCTN70010120
	Sponsor:	University of Dundee (UK)
	Date assigned:	29 March 2006

6083	Does allopurinol prevent adverse left ventricular remodelling post-myocardial infarction?
	ISRCTN:	ISRCTN57354520
	Sponsor:	University of Dundee (UK)
	Date assigned:	29 March 2006

6084	Exploring the therapeutic potential of xanthine oxidase inhibitor allopurinol in angina
	ISRCTN:	ISRCTN15253766
	Sponsor:	University of Dundee (UK)
	Date assigned:	29 March 2006

6085	Determination of safety of patients drinking before gastroscopy
	ISRCTN:	ISRCTN98555764
	Sponsor:	National Health Service Executive (UK)
	Date assigned:	29 March 2006

6086	Bioavailability of the fixed dose formulation Rifafour containing isoniazid, rifampicin pyrazinamide, ethambutol and the World Health Organization (WHO) recommended first line antiretroviral drugs zidovudine, lamivudine, efavirenz administered to new Tuberculosis (TB) patients at different levels of immunosuppression
	ISRCTN:	ISRCTN83323477
	Sponsor:	World Health Organization (WHO) (Switzerland)
	Date assigned:	29 March 2006

6087	An evaluation of the impact of early initiation of Highly Active Anti-Retroviral Therapy (HAART) on Tuberculosis (TB) treatment outcomes for TB patients co-infected with Human Immunodeficiency Virus (HIV)
	ISRCTN:	ISRCTN77861053
	Sponsor:	World Health Organization (WHO) (Switzerland)
	Date assigned:	29 March 2006

6088	A 12-week, randomised, double-blind study evaluating the effects of low-dose (10 mg) and high-dose (80 mg) atorvastatin on macrophage activity and carotid plaque inflammation as determined by ultra small super-paramagnetic iron oxide (USPIO) enhanced carotid magnetic resonance imaging (MRI)
	ISRCTN:	ISRCTN64894118
	Sponsor:	GlaxoSmithKline (UK)
	Date assigned:	29 March 2006

6089	Doxycycline Plus Streptomycin Versus Ciprofloxacin Plus Rifampicin in Spinal Brucellosis
	ISRCTN:	ISRCTN31053647
	Sponsor:	Erciyes University Medical School (Turkey)
	Date assigned:	29 March 2006

6090	Computer Assisted Management of Early Rheumatoid Arthritis-II: Does prednisone inhibit progression of joint damage if early RA is treated very intensively with disease modifying antirheumatic drugs (DMARDs)?
	ISRCTN:	ISRCTN70365169
	Sponsor:	University Medical Center Utrecht (The Netherlands)
	Date assigned:	29 March 2006

RESULT PAGE

609


© 2012 ISRCTN unless otherwise stated.